
Clearside Biomedical Inc (NASDAQ:CLSD) shares are trading higher Friday after the company reported better-than-expected fourth-quarter financial results.
Clearside reported quarterly revenue of $25.69 million, which beat the $17.77 million estimate. Clearside said it earned 31 cents per share, which beat the estimate of 16 cents per share. In the same quarter last year, Clearside reported an earnings loss of 14 cents per share.